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SpuA isa largemultimodularcellwall-attachedenzyme
involved in the degradation of glycogen by the
pathogenic bacterium Streptococcus pneumoniae.
The deletion of the gene encoding SpuA from the
bacterium resulted in a strain with reduced competi-
tiveness in a mouse model of virulence relative to the
parent strain, linking the degradation of host-
glycogen to the virulence of the bacterium. Through
the combined use of X-ray crystallography, small-
angle X-ray scattering, and inhibitor binding, the
molecular features involved in substrate recognition
by this complex protein are revealed. This uniquely
illustrates the complexity of the active site, the
conformational changes incurred during carbohy-
drate binding by this protein, and the interaction
and cooperation of its composite modules during
this process. New insight into the function of this
particular pneumococcal virulence factor is provided
along with substantial contributions to the nascent
framework for understanding the structural and func-
tional interplay between modules in multimodular
carbohydrate-active enzymes.
INTRODUCTION
One of the largest class of carbohydrate-active enzyme is
the glycoside hydrolases, members of which use a hydrolytic
mechanism to cleave glycosidic bonds (Zechel and Withers,
2001), and through this activity participate in processes of partic-
ular relevance such as those that impact the global carbon cycle
(e.g., microbial degradation of plant cell wall materials; Bayer
et al. [1998]) and those that impact human health (Gloster and
Davies, 2010). With respect to the latter, one noteworthy area
of examination regards the role of glycoside hydrolases in the640 Structure 19, 640–651, May 11, 2011 ª2011 Elsevier Ltd All rightdestruction of host glycans by microbial invaders of the human
body. Streptococcus pneumoniae, a prevalent and serious
bacterial pathogen, is one such microbe that relies on its use of
extracellular glycoside hydrolases to process a variety of host
glycans for optimal virulence (King, 2010; Higgins et al., 2009).
The extracellular pneumococcal glycoside hydrolase virulence
factors all possess complex multimodular structures, a property
generally considered as the presence of multiple structurally and
functionally distinct unitswithin a single polypeptide.Onemodule
of a glycoside hydrolase houses the catalytic machinery; in
addition to this, such an enzymemay contain numerous ancillary
modules that confer carbohydrate-binding activity (carbohy-
drate-binding modules or CBMs), protein-protein interactions,
cell-wall anchoring, and/or modules of unknown function. A
question critical to understanding the biological function of
carbohydrate-active enzymes is how the functions of the
modules are spatially coordinated to achieve a specific outcome.
This question is most powerfully addressed by the analysis of
three-dimensional structure. However, the structural heteroge-
neity of flexible, multimodular proteins has complicated the
application of structural methods to these proteins, and thus,
there are comparatively few complete structures ofmultimodular
carbohydrate-active enzymes relative to the number of single-
module structures. The best represented class of multimodular
glycoside hydrolase for which structures have been determined
are those from glycoside hydrolase family 13. Examples such
as the pullulanase from Bacillus acidopullulyticus (Turkenburg
et al., 2009), SusG from Bacteroides thetaiotaomicron (Koropat-
kin and Smith, 2010), the pullulanase (KpPulA) from Klebsiella
pneumoniae (Mikami et al., 2006), and a-amylase 1 from
Thermoactinomyces vulgaris (Abe et al., 2004) all reveal the rela-
tive dispositions of some or all of their composite modules,
including the variety of CBMs found in these proteins. Although
structures such as these are highly informative, they rarely
capture cooperation between the composite modules. Recent
advances in the application of solution small-angle X-ray scat-
tering (SAXS) to protein structure, particularly combined with
X-ray crystallography (Putnam et al., 2007), make it a comple-
mentary approach that more generally enables the completes reserved
Figure 1. In Vivo Competition Index Analysis of S. pneumoniae D39
DspuA Mutant in Three Different Host Tissues at Two Different
Times Post-Intranasal Inoculation
Each symbol indicates the CI for an individual animal. The dashed line repre-
sents the mean CI of five animals. Those mean CI values that are significantly
different from one are indicated.
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Structural Analysis of SpuAanalysis of proteins with complex modular architectures,
including carbohydrate-active enzymes (Ficko-Blean et al.,
2009; Hammel et al., 2004), which should ultimately improve
our understanding of multimodular proteins.
SpuA is a cell wall-attached protein that, like many of its GH13
family members, comprises multiple distinct modules (Bon-
gaerts et al., 2000; van Bueren et al., 2007). This enzyme hydro-
lyzes the a-1,6-branchpoints of glycogen, and the growth of
S. pneumoniae on an exogenous supply of this a-glucan is
dependent upon the presence of a functional spuA gene (Abbott
et al., 2010). A unique fused dyad of noncatalytic family 41 CBMs
at the N terminus of SpuA binds tightly to glycogen, including
glycogen in the context of type II alveolar cells in lung tissue
(van Bueren et al., 2007). SpuA is part of a group of complemen-
tary proteins involved in a-glucan metabolism, which are allStructure 19,considered part of a candidate core pneumococcal genome
(Obert et al., 2006), and many of which have been identified as
putative virulence factors in large-scale screens (Abbott et al.,
2010; Hava and Camilli, 2002). The conservation among patho-
genic streptococci of SpuA homologs, which collectively
comprise subfamily 12 of glycoside hydrolase family 13,
suggests the significance of glycogen degradation to strepto-
coccal virulence (Santi et al., 2008; Stam et al., 2006). The struc-
ture of a catalytically active truncated version of the S. agalactiae
homolog of SpuA has been determined (Gourlay et al., 2009);
however, the mode of glycogen recognition by this complex,
multimodular class of protein remains unknown. This knowledge
gap and the possible relevance of SpuA to pneumococcal viru-
lence prompted us to confirm the protein’s role in virulence.
A thorough structure-function analysis of the enzyme, incorpo-
rating X-ray crystallography in combination with SAXS, reveals
the structural changes required of SpuA to recognize glycogen
and the unprecedented role of a CBM in contributing to the archi-
tecture of the enzyme’s active site.
RESULTS
SpuA Is a Virulence Factor
To confirm the results of the large-scale signature-tagged
mutagenesis studies indicating that SpuA is important to the
pneumococcus-host interaction, we assessed the ability of
a nonpolar deletion replacement spuAmutant of S. pneumoniae
D39 (serotype 2) to compete with the wild-type D39 strain in
a mouse model. The similar numbers of wild-type and spuA
mutant bacteria isolated from the nasopharynx of intranasally
(i.n.) inoculated mice at 24 and 48 hr postinfection suggest
that SpuA plays little or no role in colonization (Figure 1).
However, the significantly reduced numbers of spuA mutant
bacteria in the lungs and blood relative to wild-type 48 hr post-
infection (p = 0.016 and 0.017, respectively) confirm a role for
SpuA in invasive disease. This observation interpreted in light
of the glycogen-degrading properties of SpuA provides robust
evidence for the link between pneumococcal virulence and
the ability of this bacterium to attack exogenous glycogen.
Nevertheless, it remains unclear if SpuA is catalytically active
on glycogen present in the cells of its host. We approached
this question by using immunofluorescence microscopy anal-
ysis of a human type II alveolar cell line (A549), which is
a common model for the analysis of adherence and invasion
by S. pneumoniae. When labeled and used as a probe for
glycogen, Thermotoga maritima CBM41, a high-affinity a-1,4
glucan-specific binding protein (Lammerts van Bueren et al.,
2004), gave intense fluorescent foci corresponding to glycogen
granules in all of the samples (Figure 2). Cells left untreated or
treated with an inactive nucleophile mutant of SpuA had a diffuse
fluorescence signal in addition to the foci (Figures 2A and 2C).
Treatment of fixed and permeabilized cells with recombinant
SpuA completely removed the diffuse fluorescence, but not
the foci, resulting in an overall decrease in fluorescence (Figures
2B and 2D). An analysis of the size of the glycogen granules (foci)
using area, circumference, and feret diameter indicated no
change in the glycogen granules upon treatment with SpuA
(see Figure S1 available online). This suggests that SpuA is rela-
tively inactive on the intracellular glycogen granules and,640–651, May 11, 2011 ª2011 Elsevier Ltd All rights reserved 641
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Figure 2. Degradation of Intracellular Glycogen in A549 Cells by Recombinant SpuA
(A) Fixed and permeabilized A549 cells probed with T. maritima CBM41 (TmCBM41), an a-glucan specific probe.
(B) Fixed and permeabilized A549 cells treated with SpuA then probed with TmCBM41.
(C) Fixed and permeabilized A549 cells treated with catalytically inactive SpuA then probed with TmCBM41.
(D) Quantification of cytoplasmic fluorescence. Error bars represent the mean (± standard error of the mean) fluorescence per unit area for a sampling of five
randomly selected regions of cytoplasm.
A supplemental analysis is found in Figure S1.
Structure
Structural Analysis of SpuAinstead, is quite active on a more dispersed form of glycogen
present in the cytoplasm of host cells.
TheX-rayCrystal Structure of SpuAReveals Its Complex
Modular Architecture
The X-ray crystal structure of a truncated recombinant form of
SpuA (SpuADCBM) comprising only the catalytic domain (the
central (a/b)8 barrel and its two flanking immunoglobulin-type
modules) was initially determined to 1.85 A˚ resolution (Figure S2).
The structure of a nearly full-length recombinant form of SpuA in
complex with maltotetraose was subsequently determined to
2.25 A˚ resolution. This crystal structure reveals the organization
of six of native SpuA’s seven domains: the two CBMs (CBM41-1
andCBM41-2); a linker domain of which only approximately 65%
of its 96 residues could bemodeled (residues 362–367, 375–381,
391–402, and 412–418 were disordered could not be built); and
the catalytic domain (Figure 3). The CBMs are folded over the top
of the (a/b)8 barrel such that the CBM41-1 module caps the
active site and creates a deep cleft between the CBM and the
(a/b)8 barrel (Figures 3B and 3C). In this cavity was clear electron
density into which could be built two molecules of maltotetraose
(Figures 3B and 3C). A second maltooligosaccharide was found
associated with CBM41-2, though only three of the four glucose
units in the bound maltotetraose molecule could be modeled
(Figure 3B and 3C).
Structural Insight into the Hydrolysis
of the a-1,6-Branchpoints in Glycogen
The twomaltotetraose molecules in the active site were bound in
a slightly offset parallel fashion (Figure 4A). The top and most
exposed maltotetraose molecule was bound quite superficially
in the active site, yetmaintained several hydrogen-bonding inter-
actions with protein side chains in addition to classic aromatic
side chain-pyranose ring interactions (Figure 4A). The second
tetrasaccharide was bound deeply in the active site, wedged
between the (a/b)8 barrel and the CBM, and made extensive
interactions with the protein, particularly with respect to interac-
tions with aromatic amino acid side chains (Figure 4A).
The canonical catalytic center of the a-amylase family (glyco-
side hydrolase family 13) comprises a trio of carboxylate groups
provided by Asp or Glu side chains (MacGregor et al., 2001;642 Structure 19, 640–651, May 11, 2011 ª2011 Elsevier Ltd All rightTurkenburg et al., 2009). In SpuA, Asp778 is found as the cata-
lytic nucleophile, Glu807 as the acid/base residue, and Asp895
as a stabilizing residue in the 1 subsite, which proposed to
make interactions with the O2 and O3 hydroxyls of the sugar.
The reducing end glucose unit of the more deeply buried malto-
tetraose is located near this catalytic center; however, it appears
slightly out of position relative to the placement of the catalytic
residues (Figure 4A). To provide additional clarity to the occupa-
tion of the ‘‘minus’’ subsites, we sought to obtain a complex of
SpuADCBM with the compound 4-O-a-D-glucopyranosylmora-
noline (G1M) (Maruo et al., 1993). Although G1M was a compar-
atively weak inhibitor of SpuA, we were able to determine
a 2.37 A˚ resolution structure of a complex with this compound
(Figure 4B). An overlay of this with the maltotetraose complex
reveals the small shift in the position of the inhibitor relative to
the maltotetraose molecule such that G1M engages Asp778
andAsp895 in amanner consistent with their proposed functions
(Figure 4C). Although G1M lacks the glycosidic oxygen (O1), its
conformation and positioning suggest that an a-configured
glycosidic oxygen (O1) of an intact a-glucoside residue, adopt-
ing the same conformation in the 1 subsite as G1M, would
be in position to hydrogen bond with Glu807, the general acid/
base residue, and be a-1,6-linked to a glucose residue in
the +1 subsite. Further support for this is given by the overlay
of the SpuA complexes with the maltotetraose complex of the
Klebsiella pneumoniae pullulanase, KpPulA (Mikami et al.,
2006), which reveals similar positioning of the sugar components
and a catalytic machinery that is poised for activity on the a-1,6-
glucosidic linkage of a branchpoint in glycogen (Figure 4D).
Consistent with these predicted roles for Asp778 and Glu807
as key catalytic residues of SpuA, substitution of these two resi-
dues to create separate Asp778Ala and Glu807Ala variants of
SpuA in both cases abolished enzyme activity (Figure S3).
A Unique Role for CBMs
The CBMs of SpuA are joined to the catalytic region via the linker
domain with the CBMs oriented so that CBM41-2 is distal from
the active site and facing outward (Figure 3). The presence of
a maltooligosaccharide bound to this module reveals that it
remains capable of recognizing an a-glucan in the context of
the complete enzyme, yet because of its distance from the actives reserved
Figure 3. Structural Analysis of SpuA
(A) The modular organization of SpuA with the crystallized construct shown
beneath.
(B) The 2.25 A˚ X-ray crystal structure of SpuA determined in complex with
maltotetraose (modules are colored according to A). The sugars are shown as
green sticks. Electron density for sugars bound to CBM41-2 (red module) and
the catalytic site (the purple module) are shown as blue mesh in the insets. The
maps are maximum-likelihood/sa-weighted 2Fobs-Fcalc maps contoured at 1s
(0.25 electrons/A˚3). Relevant aromatic residues are shown as gray sticks. The
residues acting as the acid/base and nucleophile in the catalytic site are shown
as pink and blue sticks, respectively.
Structure
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Structure 19,site, likely has no direct effect on catalysis (Figure 3). In contrast
the CBM41-1 module is positioned close to the catalytic center
and contributes to forming a portion of the enzyme active site
(Figures 3 and 4E). The three tryptophan residues that comprise
the curved surface of the CBM41-1 binding site appear to make
an integral part of substrate-binding subsites 3 and 4, sug-
gesting that the CBM plays a role in the catalytic function of
SpuA (Figure 4E). Such an intimate association of a CBM with
a catalytic center is unprecedented among carbohydrate-active
enzymes. This observation prompted us to probe the functional
relevance of this architecture by comparing the activity and inhi-
bition of SpuA and the SpuADCBM construct, which lacks the
CBMs, through the use of compounds that are predicted to
occupy these 3 and 4 subsites and, thus, interact directly
with CBM41-1.
SpuA catalyzed hydrolysis of para-nitrophenyl-a-D-maltopen-
taoside (pNP-M5, Figure 5A), a commonly used a-amylase
substrate (Eckhart, 1982), to release the colored nitrophenolate
group would necessitate its occupation of subsites +1 (by the
pNP aglycon group) to 4 (by the maltopentaoside glycon),
and perhaps a5 subsite if present (Figure 5A). As an alternative
probe of the active site, we synthesized a novel a-glucanase
inhibitor comprising maltotetraose and an O-(D-glucopyranosy-
lidene)amino N-phenylcarbamate (PUGLU) residue at the
‘‘reducing’’ terminus (referred to as PUGMAL, Figure 5B) (for
details of the synthesis, see the Supplemental Experimental
Procedures). The trigonal C-1 of the PUGLU moiety is thought
to mimic the transition state structure stabilized by such
enzymes. Accordingly, these inhibitors typically bind tightly
and such that the trigonal C1 of the PUGLU group is in the 1
subsite, and the oxime group spans the position normally occu-
pied by the scissile glycosidic bond. Consequently, PUGMAL is
predicted to interact with the same subsites as pNP-M5
(Figure 5B).
The kinetic analysis of pNP-M5 hydrolysis by SpuA yielded KM
and kcat values of 360 ± 60 mM and 270 ± 10 min
1, respectively
(Figure 5C). The corresponding values of KM and kcat for
SpuADCBM were 2100 ± 300 mM and 280 ± 20 min1, respec-
tively. The equivalent kcat values for the two proteins show that
SpuA and SpuADCBM catalyze hydrolysis of the glycosidic
bond equally well at saturating concentrations of substrate.
However, the 6-fold difference in KM suggests that the deletion
of the CBMs significantly compromises the ability of SpuA to
bind substrate. Consistent with this interpretation, SpuA
and SpuADCBM showed different binding to PUGMAL. When
using pNP-M5 as a substrate, PUGMAL was found to be
a competitive inhibitor of SpuA and gave a Ki of 18.8 ± 0.3 mM
(Figure 5D). Isothermal titration calorimetry (ITC) gave a similar
Kd at 24 ± 4 mM (Figure 5F). The limiting quantities and lower
affinity of PUGMAL for SpuADCBM only allowed us to approxi-
mate the Ki at 170 mM (Figure 5E), though the Kd determined
by ITC, 120 ± 10 mM (Figure 5G), was in fair agreement,
giving us confidence in the inhibition constant. Thus, the trunca-
tion of the CBMs in SpuADCBM results in an approximately 5- to(C) The solvent-accessible surface of SpuA with the bound maltooligo-
saccharides shown as sticks. The inset shows an expansion of the active site.
Modules are colored as in (A) and (B).
640–651, May 11, 2011 ª2011 Elsevier Ltd All rights reserved 643
Figure 4. Architecture of the SpuA Active Site and Recognition
of Sugars
(A) Two views of the SpuA active site with two maltotetraose molecules (green
sticks) occupying eight different subsites (defined according to Davies et al.,
1997). Key residues in the active site are shown as yellow sticks and potential
hydrogen bonds as black dashed lines.
(B) Two views of the active site of SpuADCBMwith a single-boundmolecule of
G1M (cyan sticks) occupying two subsites. Key residues in the active site are
shown as dark-blue sticks and potential hydrogen bonds as black dashed
lines. The blue mesh shows the electron density map for G1M as a maximum-
likelihood/sa-weighted 2Fobs-Fcalc map contoured at 1s (0.31 electrons/A˚
3).
(C) An overlay of the SpuA structure in complexwithmaltotetraose (yellow) and
the SpuADCBM-G1M complex (dark blue). The residues acting as the acid/
base (Glu807) and nucleophile (Asp778) are shown as sticks for reference.
(D) An overlay of the SpuA structure in complex withmaltotetraose (yellow), the
SpuADCBM-G1M complex (dark blue; the protein is omitted for clarity), and
the Klebsiella pneumoniae pullulanase in complex with maltotetraose
(magenta). The residues acting as the acid/base and nucleophile are again
shown as sticks for reference.
(E) The active site of SpuA in complex with maltotetraose with the components
contributed by the catalytic module shown as a solvent-accessible surface.
The CBM41-1 is shown as an orange ribbonwith the tryptophans it contributes
to the active site shown as dark-blue sticks. The sugar is shown as green
sticks, and the subsites are labeled. The previously determined structure of
CBM41-1 in complex with maltotetraose (van Bueren et al., 2007) is shown in
purple and overlapped with CBM41-1 of the SpuA structure.
Supplemental data are found in Figure S2.
Structure
Structural Analysis of SpuA8-fold decrease in affinity for the inhibitor, which is consistent
with the 6-fold change in KM for pNP-M5. Taken together, these
results reveal that deletion of the CBMs and, thus, loss of poten-644 Structure 19, 640–651, May 11, 2011 ª2011 Elsevier Ltd All righttial interactions at 3 and 4 subsites to some degree compro-
mise the ability of the enzyme to recognize carbohydrates.
The activity of SpuA and SpuADCBM was further explored by
semiquantitative HPAEC-PAD analysis of glycogen hydrolysis by
these proteins. Both proteins produced the same series of oligo-
saccharides upon glycogen hydrolysis (data not shown), as was
previously described (Abbott et al., 2010). However, analysis of
the production of maltooligosaccharides from maltotriose (M3)
to maltooctaose (M8) over the reaction time course showed
that relative to SpuA, SpuADCBM was roughly half as effective
at releasing these oligosaccharides from glycogen (Figure 6;
Figure S4). Thus, in addition to playing a role in the recognition
of smaller compounds, such as pNP-M5 and PUGMAL, the
CBMs also have a role in promoting degradation of the highly
polymerized substrate glycogen.
These results corroborate the proposed structural role of
CBM41-1 in forming part of the active site and contributing to
substrate recognition. However, the position of CBM41-1 in
the crystal structure blocks off the active site immediately
beyond the 4 subsite, which is made particularly clear through
comparisons of the previously determined structure of CBM41-1
in complex with maltotetraose with the structure of CBM41-1 in
the context of the SpuA active site (Figure 4E). Contradictory to
this is the observed recognition of pNP-M5, PUGMAL, and
glycogen, which necessitates that sugar chains extend beyond
the 4 subsite. Consequently, it appeared to us that molecular
motions in SpuA must enable movement of the CBMs relative
to the catalytic domain so as to accommodate longer chains in
the minus subsites and generally allow substrate to access the
deep active site cleft. Unfortunately, uncomplexed SpuA was,
despite extensive attempts, completely recalcitrant to crystalli-
zation, so we approached this hypothesis through the analysis
of the solution structure properties of SpuA with SAXS.
SpuA Undergoes Conformational Changes
Three different concentrations of SpuA were analyzed by
solution SAXS (Table 1). For each concentration of protein,
20 ab initio models were generated with DAMMIF, which gave
average c values of 1.4–2.1 and normalized spatial discrep-
ancies of 0.6–0.7. The averaged ab initio form of SpuA in solu-
tion reveals a triangular shape that qualitatively matches the
general shape of the complexed crystal structure of SpuA (Fig-
ure 7A). However, the best ccrysol value generated using the
complexed crystal structure as a model for the SAXS data
was obtained using the data collected on 2.95 mg/ml SpuA,
yet the value was relatively poor at 3.4, indicating that the
closed form of SpuA trapped in the crystal structure is not an
optimal model of SpuA in solution. To generate more suitable
pseudoatomic models of uncomplexed SpuA in solution, two
approaches were taken. Both approaches required that the
coordinates of SpuA obtained from the X-ray crystallographic
analysis be separated into two rigid bodies: the CBMs and
linker domain as one rigid body (referred to as the N-fragment);
and the catalytic domain as a second rigid body (referred to as
the C-fragment). In the first approach the N- and C-fragments
were manually placed into the ab initio envelope using the
positions of the N and C termini that would join the two frag-
ments as a constraint. The relative positions of the fragments
were optimized based on calculated ccrysol values. The finals reserved
Figure 5. Activity and Inhibition of SpuA
and SpuADCBM
(A) Schematic showing the structure of pNP-
a-maltopentaoside (pNP-M5) and its predicted
occupation of subsites. The catalytic residues are
shown for reference.
(B) Schematic showing the structure of PUGMAL
and its predicted occupation of subsites.
(C) Kinetic curves for the activity of SpuA (open
circles) and SpuADCBM (closed circles) on
pNP-M5. The results of nonlinear fitting to deter-
mine theMichaelis-Menton parameters are shown
as solid lines.
(D and E) Dixon plots of (D) SpuA and (E)
SpuADCBM inhibition by PUGMAL are shown.
Ki values determined at the intersection points of
the lines are shown.
(F and G) ITC analysis of (F) SpuA and (G)
SpuADCBM binding to PUGMAL is shown. The
raw titration data are shown in the top panes, and
the integrated heats are shown as closed squares
in the bottom panes. The results of data fitting as
outlined in the Experimental Procedures are
shown as solid lines.
Structure
Structural Analysis of SpuAmodel obtained, referred to as model 1, had a ccrysol value of
1.9 (Figure 7B). Owing to the potentially flexible nature of
SpuA in solution and the possible presence of a wide variety
of conformations not accounted for in the manual generation
of a SpuA model, the second approach used the ensemble
optimization method (EOM) (Bernado et al., 2007) to model
the SAXS data by treating the polypeptide region between the
N- and C-fragments as a flexible hinge. The resulting ensembleStructure 19, 640–651, May 11, 2011of 20 SpuA models yielded an overall
cEOM value of 2.1, with a range of ccrysol
values calculated for the individual
models between 1.8 and 2.5; the best
model with a ccrysol of 1.8 is referred to
as model 2 (Figure 7C). Notably, the
manually generated model was a rela-
tively close match to several of the
individual EOM models. A comparison
of the SAXS-based models, both manu-
ally generated and the EOM generated,
with the complexed crystal structure
of SpuA show the possible solution
structures of SpuA to be in quite different
conformations than in the crystal struc-
ture (Figure 7D). The general properties
of all of the solution models reveal
that the active site of the uncomplexed
form is substantially more open, which
is achieved through the retraction of
the CBMs from the active site by 20–
40 A˚. SAXS analysis of SpuA in solution
in the presence of excess maltotetraose
was also performed, and although
the analysis of the data was complicated
by the high background scattering of the
oligosaccharide, the results suggesteda generally closed conformation consistent with the X-ray
crystal structure (data not shown).
DISCUSSION
The identification of SpuA as a virulence factor and its activity on
glycogen present in a type II alveolar cell line link the glycogen-
degrading ability of this protein to the pathogenesis of theª2011 Elsevier Ltd All rights reserved 645
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Figure 6. SpuA Catalyzed Degradation of Glycogen
SpuA (circles) and SpuADCBM (squares) catalyzed release of maltotetraose
(A), maltohexaose (B), and maltooctaose (C) from glycogen over time as
measured by HPAEC-PAD. The PAD response refers to the integrated
peak area of the oligosaccharide being monitored in nanocoulombs per
minute (nC/min). This value is proportional to the concentration of that
oligosaccharide; thus, a comparison of the SpuA and SpuADCBM curves for
release of a given oligosaccharide gives a relative measure of activity. Error
bars represent the standard deviation of triplicate measurements. Supple-
mental data describing the standards there were utilized and additional
maltooligosaccharides that were monitored are found in Figure S4.
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646 Structure 19, 640–651, May 11, 2011 ª2011 Elsevier Ltd All rightbacterium. The overall dimensions of SpuA, provided by its
structure, suggest that it can extend 11–12 nm from the
peptidoglycan to which it is attached. The capsule layer of the
pneumococcus is estimated to extend >100 nm from the cell
wall, though this is dependent upon the serotype (Hyams et al.,
2010). Therefore, the capsule would present a substantial phys-
ical barrier to the access of a large polysaccharide like glycogen
to the SpuA active site. Consistent with this proposal, the
pneumococcus grows poorly on glycogen in culture, but growth
similar to that on glucose is obtained if cultures are supple-
mented with exogenous recombinant SpuA to depolymerize
the glycogen into smaller soluble fragments that could more
easily diffuse through the capsule layer (Abbott et al., 2010).
The implication is that the effect of SpuA is exerted depending
on the capsular status of the bacterium while it is in the host.
This further suggests that the optimum efficiency of SpuA is
achieved when the pneumococcus is unencapsulated, such as
after the bacterium has invaded a host cell (Hammerschmidt
et al., 2005), or in a less-encapsulated ‘‘transparent’’ phase,
which predominates at mucosal surfaces. Considering that
glycogen is an intracellular energy store that is abundant in
type II alveolar cells, we favor a model whereby SpuA degrades
intracellular glycogen following invasion of this host cell type
when the bacterium is unencapsulated, though the degradation
of glycogen released by lysed host cells is also plausible (Abbott
et al., 2010; van Bueren et al., 2007).
Although structural changes in proteins upon carbohydrate
recognition are not uncommon (Quiocho et al., 1997; Nishimasu
et al., 2007), SpuA presents a noteworthy case that results
mainly from its large size and multimodularity. The glycoside
hydrolase family 13 catalytic domain imparts the key hydrolytic
activity to the enzyme; however, one of the most remarkable
features revealed by the X-ray crystal structure of a nearly full-
length fragment of SpuA is the position of its CBMs. The
N-terminal CBM, CBM41-1, folds back to cover the active site,
which created3 and4 subsites and, overall, a complex active
site with at least eight subsites through which SpuA recognizes
and hydrolyzes the a-1,6-branchpoints in glycogen. Such an
architecture has not yet been observed in a carbohydrate-active
enzyme, and the consequence is a very deep active site with
minus subsites that nearly completely sequester the ‘‘arm’’ of
the glycogen branchpoint that is being removed. This indicates
complexities in the recognition of glycogen, including, at the
extreme, an inability to hydrolyze the branchpoints of granular
glycogen where the aggregation of the a-glucan chains and
concomitant steric effects would limit accessibility to the deep
active site of the enzyme. Consistent with this, SpuA appeared
to be inactive on intracellular glycogen granules. Instead, the
enzyme was selective for a more dispersed form of cellular
glycogen, suggesting that SpuA requires the more accessible
branchpoints in less aggregated or soluble glycogen. However,
the crystal structure of SpuA shows the active site in this trapped
form of the protein to be blocked off beyond the 4 subsites,
thus predicting that only branches having four or less sugar
residues could be removed from glycogen by SpuA. This is at
odds with the observed endo-glycogenase activity of SpuA,
where the products of glycogen hydrolysis range from glucose
to maltooligosaccharides with a very high degree of polymeriza-
tion (Abbott et al., 2010). Thus, though highly informative, thes reserved
Table 1. SAXS Parameters for SpuA
Concentration (mg/ml) Calculated MW (kDa)a Rg(Guinier) (A˚) Rg(Gnom) (A˚) Dmax (A˚) c(dammif)
Normalized Spatial
Discrepancy
11.4 115.1 36.1 35.7 115 1.7 ± 0.1 0.7 ± 0.1
7.74 115.6 33.9 35.4 110 2.1 ± 0.1 0.6 ± 0.1
2.95 126.3 37.7 37.7 120 1.4 ± 0.1 0.7 ± 0.1
a The expected molecular weight for SpuA is 130 kDa for this 1137 amino acid polypeptide. The molecular weight was determined from the SAXS data
by the method of Fischer et al. (2010).
Structure
Structural Analysis of SpuAcrystal structure of SpuA likely represents only one possible
trapped form of the protein because the observed recognition
and hydrolysis of larger substrates must require a degree of
malleability in the spatial organization of the protein’s composite
modules to accommodate the substrate.
The presence of conformational flexibility in SpuA is sup-
ported by our analysis of the solution structure of SpuA, which
reveals a conformation with the dyad of CBMs significantly
retracted from the active site, thus allowing access to the
substrate. A comparison of the solution structure of SpuA with
the complexed crystal structure revealed that carbohydrate
recognition by this protein requires a conformational trajectory
that ranges from a somewhat open active site in the absence
of substrate to the closed form observed in the crystal structure.
This motion markedly resembles a hammer descending upon onStructure 19,an anvil. The CBM-dyad forms the head of the hammer and the
linker domain the handle of the hammer, whereas the catalytic
domain comprises the anvil. CBM41-2 makes up one side of
the hammerhead, which remains distal from the active site and
poised to interact with glycogen in a noncatalytic, adherent
role. During the recognition of substrate, the hammer closes in
on the anvil, allowing CBM41-1 to pin a substrate, which may
be already bound in the active site. Alternatively, it is also
plausible that CBM41-1 may play a role in first binding then
delivering the substrate to the catalytic machinery as the
hammer closes on the anvil. In either case, conformational
flexibility, which appears to be a feature of the enzyme’s multi-
modular nature, imparts the plasticity necessary for SpuA to
recognize and hydrolyze a structurally complex substrate such
as glycogen.Figure 7. Solution Structure of SpuA
Determined by SAXS Analysis
(A) Ab initio model of SpuA created from the
average of 20 models generated by DAMMIF.
(B) Model 1 of SpuA generated by manually
placing the N-terminal fragment of SpuA (CBMs
and linker) and the C-terminal fragment (Ig-
domains and (a/b)8-barrel) into the ab initio form.
(C) The ensemble of SpuA structures obtained
from application of the EOM is shown in divergent
stereo. The 20 models of the ensemble and the
crystal structure were overlapped via the
C-terminal catalytic domain (shown as a gray
cartoon). The EOM models are shown as gray
ribbons. The individual EOM-derived model giving
the best individual ccrysol of 1.8, referred to as
model 2, is shown in a purple cartoon represen-
tation. The CBMs from the crystal structure are
shown in blue cartoon representation.
(D) A comparison of the manually derived model 1
(yellow) with the best EOM model 2 (purple) and
the X-ray crystal structure (blue). The models were
overlapped via their catalytic modules, which are
shown in gray. The residues on CBM41-1 that
participate in forming the 3 and 4 subsites are
shown as sticks.
In both (C) and (D), the sugars bound in the active
site of SpuA in the crystal structure are shown in
stick representation for reference.
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Structural Analysis of SpuAThe generally accepted paradigm of CBM function is one
where CBMs are proposed to contribute to enzyme catalysis
mainly by targeting the complete enzyme to a portion of the
substrate that is near (on the order of the dimensions of the
protein), but not immediately adjacent to the glycosidic bond
being cleaved (Bolam et al., 1998; Boraston et al., 2004). This
concept was established primarily on numerous observations
that the truncation of CBMs from carbohydrate-active enzymes
results in an enzyme with lowered activity on polysaccharides,
most frequently insoluble polysaccharides. The best-known
deviation from this paradigm is found among the glycoside
hydrolase family 9 endoglucanases. Some of these enzymes
have family 3c CBMs that are found at the immediate C terminus
of the catalytic domain; the structures of these proteins reveal
the CBM to be rigidly appended to the catalytic domain (Mandel-
man et al., 2003; Sakon et al., 1997). Consistent with the para-
digm, deletion of the CBM reduces the activity of the enzyme,
providing evidence of its importance in substrate recognition
(Irwin et al., 1998). However, the unique feature of these
cellulases is that the binding site of the CBM aligns with catalytic
site, suggesting its role in extending the substrate-accommo-
dating subsites of the active site (Mandelman et al., 2003; Sakon
et al., 1997). SpuA also displays the expected paradigm ‘‘pheno-
type’’ of reduced activity when its CBMs are truncated. However,
the structural analysis presented here indicates a substantial
departure from the paradigm because the mode of substrate
recognition by SpuA not only utilizes a CBM that is intimately
associated with the active site, but substrate recognition
also appears to be accompanied by conformational changes.
These conformational changes involve a large portion of the
enzyme’s modular architecture and ultimately allow the CBM
to retract from the active site and close in on the active site, likely
to accommodate the somewhat heterogeneous glycogen
substrate. These examples highlight the need to appreciate the
overall three-dimensional structures of complete multimodular
carbohydrate-active enzymes and the modular cooperation
that this can reveal.
EXPERIMENTAL PROCEDURES
Construction of S. pneumoniae spuA Mutant
A defined, nonpolar deletion replacement mutant of spuA in S. pneumoniae
D39 (serotype 2) was constructed by overlap-extension PCR essentially as
described previously (Stroeher et al., 2007) (see also Supplemental Experi-
mental Procedures).
Virulence Studies
D39 and D39DspuA were inoculated from an overnight blood agar plate
into serum broth (SB) and grown to a culture density of approximately 1 3
108 cfu/ml. The bacteria were then diluted to the appropriate dose in sterile
SB. Two groups of mice were injected i.n. with approximately 107 cfu total
of a 1:1 mixture of D39wt:D39DspuA in 50 ml of SB. Before i.n. challenge,
mice were anesthetized by intraperitoneal injection of Nembutal (pentobarbi-
tone sodium; Rhone-Merieux) at a dose of 66 mg/g of body weight. The actual
dose of bacteria administered was confirmed retrospectively by plating serial
dilutions of the challenge inocula after administration to the mice. At 24 and
48 hr postinfection, bacteria were harvested from the nasopharynx, lungs,
and blood of mice as described previously (Stroeher et al., 2007). Samples
were serially diluted and plated on blood agar with or without erythromycin
to enumerate wild-type and mutant pneumococci. Competitive indices
between wild-type and mutant were analyzed using Student’s one-sample
t test (two-tailed).648 Structure 19, 640–651, May 11, 2011 ª2011 Elsevier Ltd All rightCloning, Recombinant Production, and Purification of Recombinant
Proteins
A nearly full-length construct of SpuA, referred to as SpuA throughout, encod-
ing a polypeptide lacking C-terminal LPXTGmotif and the first 134 amino acids
(omission of this N-terminal fragment resulted in a more stable polypeptide)
was cloned, produced, and purified by immobilized metal affinity chromatog-
raphy as described previously (Abbott et al., 2010). A more truncated DNA
fragment encoding only the catalytic domain (amino acid residues 446–
1245; SpuADCBM) and mutants of SpuA were generated and produced,
purified, and quantified by standard molecular biology procedures (see
Supplemental Experimental Procedures for details).
Immunofluorescence Microscopy
Cells (A549; ATCC CCL-185) were cultured in DMEM:F12, containing 10%
FBS, 2 mM L-Glutamine, and 1 mM sodium pyruvate, and passaged into
8-well slide chambers. Cells were rinsed in PBS and fixed in 4% paraformalde-
hyde in PBS (15 min), rinsed, and blocked in 5% lamb serum in PBS Tween
20 (15 min, room temperature). Cells were treated with 2.5 mg/ml enzyme
(SpuA or SpuAD778A), diluted in 20 mM Tris-HCl (pH 8.0), overnight at room
temperature. Cells were rinsed three times in PBS before application of
1 mg/ml FITC-labeled CBM41 from T. maritima. FITC labeling of TmCBM41
was performed according to the manufacturer’s guidelines (Sigma). Slides
were mounted with coverslips and examined with an Olympus FluoView
FV1000 laser-scanning confocal microscope. Single optical sections (1 mm)
of fields of cells were collected, and fluorescence intensity per unit area was
determined within a 5 3 5 mm sample area placed over the cytoplasm of cells
chosen at random in monochrome images using ImageJ (version 1.43 m).
Overall contrast and brightness were adjusted, and images were cropped
and assembled using Photoshop (CS2). Statistical analysis (one-way
ANOVA, Bonferroni’s multiple comparison test) was done with GraphPad
Prism (5.03).
Inhibitor Synthesis
The synthesis of maltopentaose-phenyl carbamate (PUGMAL) was performed
as outlined in the Supplemental Experimental Procedures.
Enzyme Kinetics
All steady-state kinetic studies were carried out at 25C in a Cary/Varian
300 Bio UV-Visible Spectrophotometer. Standard reaction mixtures for the
determination of kinetic constants were done in PBS in 1 ml volumes contain-
ing 200 nM SpuA or SpuADCBM and 0–4 mM pNP-M5. The 4-nitrophenolate
productionwasmonitored at 400 nm; rateswere calculated using an extinction
coefficient, 3400nm, of 7790 cm
1M1. All experiments were performed in
triplicate. Michaelis-Menten parameters were determined by nonlinear curve
fitting using Origin7. The Ki value for SpuA or SpuADCBM inhibition by
PUGMAL was determined using pNP-M5 as a substrate and by linear regres-
sion analysis of Dixon plots. The analysis of glycogen hydrolysis was
performed as described in the Supplemental Experimental Procedures.
Binding Analysis
ITC was performed as described previously using a VP-ITC (MicroCal, North-
ampton, MA, USA) (van Bueren et al., 2007). Briefly, SpuA and SpuADCBM
were extensively dialyzed against buffer (50 mM Tris HCl [pH 7.5]) then
concentrated in a stirred ultrafiltration cell as above. PUGMAL solutions
were prepared by mass in buffer saved from the ultrafiltration step. Both
protein and sugar solutions were filtered and degassed immediately prior to
use. The protein concentrations used were 50–200 mM. Titrations were
performed at 25C. The SpuADCBM data were fit with a single binding site
model to determine the dissociation constant. The SpuA data were more
complicated and could not be adequately fit with a single binding site model.
It was reasoned, on the basis of the structure of the protein, that this was due to
binding in the active site as well as to the distal CBM41-2 module. We had
previously determined the thermodynamics of maltotetraose recognition by
CBM41-2 (van Bueren et al., 2007); thus, we fit the SpuA data to a two-site
binding model, setting one class of binding site as a constant with parameters
equal to those determined for CBM41-2. Due to limiting amounts of reagents,
only single titrations could be performed; reported errors are those determined
by model fitting.s reserved
Table 2. X-ray Data Collection and Structure Refinement Statistics
SpuADCBM SpuADCBM with G1M SpuA with Maltotetraose
Data Collection
Space group P21 P21 P212121
Cell dimensions
a, b, c (A˚) 57.57, 75.20, 87.04 (b = 97.31) 57.78, 75.80, 88.09 (b = 97.72) 80.14, 86.43, 193.22
Resolution (A˚) 20.00–1.85 (1.92–1.85)a 20.00–2.37 (2.48–2.37) 20.00–2.25 (2.33–2.25)
Rmerge 0.057 (0.403) 0.081 (0.250) 0.086 (0.396)
<I/sI > 10.2 (2.3) 5.8 (2.6) 9.4 (2.8)
Completeness (%) 96.7 (94.1) 90.0 (91.1) 92.6 (94.8)
Redundancy 3.73 (3.64) 2.23 (2.14) 4.25 (4.18)
Refinement
Number of reflections 57,697 25,638 56,573
Rwork/Rfree 0.17/0.23 0.21/0.26 0.21/0.27
Number of atoms
Protein 5,708 5,636 7,880
Ligand/ion 1 (Na)/24 (GOL)/1 (Ca) 22 (G1M)/1 (Ca)/1 (Na) 124 (GLC)/4 (Na)/5 (SO4)
Water 839 206 715
B factors
Protein 26.2 26.5 34.6
Ligand/ion 15.4 (Na)/34.0 (GOL)/27.5 (Ca) 18.2 (G1M)/23.4 (Ca)/13.0 (Na) 34.2 (GLC)/40.8 (Na)/33.7 (SO4)
Water 38.1 24.6 38.5
Rms deviation
Bond lengths (A˚) 0.024 0.014 0.011
Bond angles () 1.927 1.440 1.348
Ramachandran (%)
Favored 97.1 96.3 95.4
Allowed 2.8 3.5 4.6
Outliers 0.1 0.1 0.0
aNumbers in parenthesis indicate values for the highest resolution shell.
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Structural Analysis of SpuACrystallization
Crystallization was performed using the vapor diffusion hanging drop method.
Crystals of SpuADCBM (5 mg/ml) were obtained in 17.5% PEG 3350, 0.2 M
MgCl2, 0.1 M sodium acetate (pH 5.5), and 3% glycerol. SpuADCBM was
complexed with 4-O-a-D-glucopyranosylmoranoline (Toronto Research
Chemicals) by soaking a crystal in crystallization solution containing 2 mM of
the compound. Crystals of SpuA (15 mg/ml) that was precomplexed with
maltotetraose (at 5 mM) grew in 2 M (NH4)2SO4, 0.2 M Na/K Tartrate, 0.1 M
tri-sodium citrate (pH 5.6), supplemented with 3%glycerol. Crystals were flash
cooled in liquid nitrogen using a cryoprotectant comprising crystallization
solution supplemented with 20% glycerol for SpuADCBM and 15% glycerol
for SpuA.
X-ray diffraction data sets were collected on a Rigaku R-AXIS 4++ area
detector coupled to a MM-002 X-ray generator with Osmic ‘‘blue’’ optics
and an Oxford Cryostream 700. Data were processed with CrystalClear/
d*trek (Pflugrath, 1999). Data collection and processing statistics are given
in Table 2. The structure of SpuADCBMwas solved by molecular replacement
using MOLREP (Vagin and Teplyakov, 2000) with the Klebsiella pneumoniae
pullulanase catalytic module coordinates as a search model (PDB code
2FHF) (Mikami et al., 2006). The initial model was corrected and completed
manually by successive rounds of building using Coot (Emsley and Cowtan,
2004) and refinement with REFMAC (Murshudov et al., 1997). SpuAwas solved
bymolecular replacement with MOLREP using the coordinates of SpuADCBM
and the CBM dyad (PDB code 2J44) as search models. The initial model of
SpuA was manually completed, corrected, and refined as above.
In all cases, water molecules were added using COOT:FINDWATERS
and inspected visually prior to deposition. Of the observations 5% wereStructure 19,flagged as ‘‘free’’ and used to monitor refinement procedures (Brunger,
1992). Model validation was performed with SFCHECK (Vaguine et al., 1999)
and PROCHECK (Laskowski et al., 1993). All data collection and model statis-
tics are given in Table 2.
SAXS
Synchrotron X-ray scattering data from solutions of SpuA from 2.95 to
11.4 mg/ml were collected at the X33 beamline of the EMBL (DESY,
Hamburg) using a MAR345 image plate detector. A 4.2 mg/ml solution of
BSA was measured as a reference and for calibration. The scattering patterns
were measured with an exposure time of 2 min at 288 K. The wavelength was
1.5 A˚. The sample-to-detector distance was set at 2.4 m, leading to
scattering vectors Q ranging from 0.06 to 0.5 A˚1. Data processing and
determination of Rg, and Dmax were performed as described previously
(Ficko-Blean et al., 2009).
The ab initio low-resolution envelopes of SpuA were generated with
DAMMIF (Franke and Svergun, 2009) using 20 independent runs with no shape
constraints. The ab initio reconstructions were aligned, averaged, and filtered
using the DAMAVER (Volkov and Svergun, 2003) suite of programs. SpuA was
considered as a two-domain protein, with the first domain the two CBMs and
the linker region (amino acids 130–436), and the second domain the catalytic
module (amino acids 437–1143); these two domains were manually fit into the
filtered envelope. The goodness of fit for all atomic models with the experi-
mental data was determined using the discrepancy c, defined according to
Konarev et al. (2003). The solution scattering for the models, the fit to the
experimental curve, and the goodness of fit was evaluated using CRYSOL
(Svergun et al., 1995).640–651, May 11, 2011 ª2011 Elsevier Ltd All rights reserved 649
Structure
Structural Analysis of SpuAEOM (Bernado et al., 2007) was applied to the SAXS data as follows.
The polypeptide region (aa 435–438) between the linker domain and the
N-domain of the catalytic module was treated as a ‘‘hinge,’’ and a random
pool of 10,000 conformers was generated around the flexible hinge using
RANCH fromwhich the genetic algorithmGAJOE selected the ensemble fitting
the experimental data. EOM modeling of native SpuA was done using data
collected on the 2.95 mg/ml concentration of SpuA. Both data sets were
analyzed over a Q range of 0.06–0.5 A˚1. The number of ensembles to
compare to the experimental data was set at 50, and the number of genera-
tions the genetic algorithm used to optimize the ensemble was 1000, with
20 crossings per generation and 50 repetitions. c values were determined
for the ensembles during EOM modeling and separately for the individual
ensemble models using the program CRYSOL (Svergun et al., 1995).
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